Selective reduction of fatty acid oxidation in colonocytes: correlation with ulcerative colitis
- PMID: 2127822
- DOI: 10.1007/BF02536016
Selective reduction of fatty acid oxidation in colonocytes: correlation with ulcerative colitis
Abstract
Attempts were made to define which fatty acid (2:0 to 18:1) was optimally oxidized by isolated colonocytes (colonic epithelial cells) and to select inhibitors of fatty acid oxidation which would be analogous in their action to the inhibition of fatty acid oxidation observed in colonocytes involved with ulcerative colitis. Isolated colonic epithelial cells of Sprague-Dawley rats were used with 2-mercaptoacetate, dichloroacetate, 3-mercaptopropionate, 4-mercaptobutyrate, 4-sulfatebutyrate, 2-bromobutyrate, sulfite ions and nitrite ions. n-Butyrate (4:0) was maximally oxidized to CO2 and ketone bodies (mean value 5.46 mumols/min/g dry wt). Oxidation of butyrate to CO2 was diminished by 2-bromobutyrate, sulfite ions and all mercapto fatty acids. Both fatty acid oxidation and glucose oxidation were significantly inhibited by 2-bromobutyrate, while mercapto fatty acids and sulfite inhibited fatty acid oxidation (p less than 0.01) without significantly changing glucose oxidation. Observation with 2-mercaptoacetate and sulfite correlate with early changes of fatty acid oxidation observed in cases of ulcerative colitis, and warrant further study with isolated colonocytes of man.
Similar articles
-
Influence of feces from patients with ulcerative colitis on butyrate oxidation in rat colonocytes.Dig Dis Sci. 1999 Oct;44(10):2099-109. doi: 10.1023/a:1026642923168. Dig Dis Sci. 1999. PMID: 10548364
-
Selective inhibition of fatty acid oxidation in colonocytes by ibuprofen: a cause of colitis?Gut. 1995 Jan;36(1):55-9. doi: 10.1136/gut.36.1.55. Gut. 1995. PMID: 7890237 Free PMC article.
-
Sulphide impairment of substrate oxidation in rat colonocytes: a biochemical basis for ulcerative colitis?Clin Sci (Lond). 1993 Nov;85(5):623-7. doi: 10.1042/cs0850623. Clin Sci (Lond). 1993. PMID: 8287651
-
Metabolism of large bowel mucosa in health and disease.Int J Colorectal Dis. 1991 May;6(2):127-32. doi: 10.1007/BF00300209. Int J Colorectal Dis. 1991. PMID: 1875122 Review. No abstract available.
-
Butyrate and the colonocyte. Production, absorption, metabolism, and therapeutic implications.Adv Exp Med Biol. 1997;427:123-34. Adv Exp Med Biol. 1997. PMID: 9361838 Review.
Cited by
-
Revisiting the "starved gut" hypothesis in inflammatory bowel disease.Immunometabolism (Cobham). 2023 Jan 10;5(1):e0016. doi: 10.1097/IN9.0000000000000016. eCollection 2023 Jan. Immunometabolism (Cobham). 2023. PMID: 36644501 Free PMC article. Review.
-
The long-term consequences of antibiotic therapy: Role of colonic short-chain fatty acids (SCFA) system and intestinal barrier integrity.PLoS One. 2019 Aug 22;14(8):e0220642. doi: 10.1371/journal.pone.0220642. eCollection 2019. PLoS One. 2019. PMID: 31437166 Free PMC article.
-
Expression and Metabolomic Profiling in Axial Spondyloarthritis.Curr Rheumatol Rep. 2018 Jun 27;20(8):51. doi: 10.1007/s11926-018-0756-y. Curr Rheumatol Rep. 2018. PMID: 29951774 Review.
-
Butyrate decreases its own oxidation in colorectal cancer cells through inhibition of histone deacetylases.Oncotarget. 2018 Jun 5;9(43):27280-27292. doi: 10.18632/oncotarget.25546. eCollection 2018 Jun 5. Oncotarget. 2018. PMID: 29930765 Free PMC article.
-
Plasma, urine and ligament tissue metabolite profiling reveals potential biomarkers of ankylosing spondylitis using NMR-based metabolic profiles.Arthritis Res Ther. 2016 Oct 22;18(1):244. doi: 10.1186/s13075-016-1139-2. Arthritis Res Ther. 2016. PMID: 27770826 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical